Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): Implications for the design of therapeutic trials in patients with advanced symptomatic KS [3]

Journal of Clinical Oncology

Volumn 23, Issue 10, 2005, Pages 2433-

  Nasti, Guglielmo ^a   Tirelli, Umberto ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INFORMATION PROCESSING; KAPOSI SARCOMA; LETTER; LUNG DISEASE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; METHODOLOGY; NOTE; PATIENT SELECTION; SURVIVAL; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS; PATIENT SELECTION; PROGNOSIS; RESEARCH DESIGN; SARCOMA, KAPOSI; SURVIVAL ANALYSIS;

EID: 17144402197     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.790     Document Type: Letter

References (3)

1. Krown SE: Highly Active Antiretroviral Therapy in AIDS-associated Kaposi's sarcoma: Implication for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J Clin Oncol 22:399-402, 2004
2. Nasti G, Talamini R, Antinori A, et al: AIDS-related Kaposi's sarcoma: Evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group staging system in the HAART era-The Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naïve from Antiretrovirals. J Clin Oncol 21:2876-2882, 2003
3. Krown SE, Testa M, Huang J: AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification. J Clin Oncol 15:3085-3092, 1997